Kellie Toohey1,2, Maddison Hunter3,4, Karen McKinnon5, Tamara Casey5, Murray Turner3, Suzanne Taylor5, Catherine Paterson3,4,6. 1. Faculty of Health, University of Canberra, Bruce ACT, 2617, Australia. kellie.toohey@canberra.edu.au. 2. Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, University of Canberra, Bruce ACT, Australia. kellie.toohey@canberra.edu.au. 3. Faculty of Health, University of Canberra, Bruce ACT, 2617, Australia. 4. Prehabilitation, Activity, Cancer, Exercise and Survivorship (PACES) Research Group, University of Canberra, Bruce ACT, Australia. 5. Australian Capital Territory Breast Care, Calvary Public Hospital, Bruce ACT, Australia. 6. Robert Gordon University, Aberdeen, AB10 7QB, Scotland.
Abstract
PURPOSE: Breast cancer is the most prevalent malignancy in women. Prehabilitation may offer improvements in physical and psychological wellbeing among participants prior to treatment. This systematic review aimed to determine the efficacy of prehabilitation in participants diagnosed with breast cancer. METHODS: A systematic review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Guidelines. Studies exploring the impact of prehabilitation in participants with breast cancer were included. Studies were assessed independently according to pre-eligibility criteria, with data extraction and methodological quality assessed in parallel. RESULTS: 3184 records were identified according to our search criteria, and 14 articles were included. Articles comprised of quantitative randomised controlled trials (n = 7), quantitative non-randomised studies (n = 5), a qualitative study (n = 1), and a mixed-method study (n = 1). The majority of selected studies completed exercise programs (n = 4) or had exercise components (n = 2), with two focusing on upper-limb exercise. Five articles reported complementary and alternative therapies (n = 5). Two articles reported smoking cessation (n = 2), with a single study reporting multi-modal prehabilitation (n = 1). Mostly, prehabilitation improved outcomes including physical function, quality of life, and psychosocial variables (P < 0.05). The qualitative data identified preferences for multimodal prehabilitation, compared to unimodal with an interest in receiving support for longer. CONCLUSIONS: Prehabilitation for patients with breast cancer is an emerging research area that appears to improve outcomes, however, ensuring that adequate intervention timeframes, follow-up, and population groups should be considered for future investigations. IMPLICATIONS FOR CANCER SURVIVORS: The implementation of prehabilitation interventions for individuals diagnosed with breast cancer should be utilised by multidisciplinary teams to provide holistic care to patients as it has the potential to improve outcomes across the cancer care trajectory.
PURPOSE: Breast cancer is the most prevalent malignancy in women. Prehabilitation may offer improvements in physical and psychological wellbeing among participants prior to treatment. This systematic review aimed to determine the efficacy of prehabilitation in participants diagnosed with breast cancer. METHODS: A systematic review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Guidelines. Studies exploring the impact of prehabilitation in participants with breast cancer were included. Studies were assessed independently according to pre-eligibility criteria, with data extraction and methodological quality assessed in parallel. RESULTS: 3184 records were identified according to our search criteria, and 14 articles were included. Articles comprised of quantitative randomised controlled trials (n = 7), quantitative non-randomised studies (n = 5), a qualitative study (n = 1), and a mixed-method study (n = 1). The majority of selected studies completed exercise programs (n = 4) or had exercise components (n = 2), with two focusing on upper-limb exercise. Five articles reported complementary and alternative therapies (n = 5). Two articles reported smoking cessation (n = 2), with a single study reporting multi-modal prehabilitation (n = 1). Mostly, prehabilitation improved outcomes including physical function, quality of life, and psychosocial variables (P < 0.05). The qualitative data identified preferences for multimodal prehabilitation, compared to unimodal with an interest in receiving support for longer. CONCLUSIONS: Prehabilitation for patients with breast cancer is an emerging research area that appears to improve outcomes, however, ensuring that adequate intervention timeframes, follow-up, and population groups should be considered for future investigations. IMPLICATIONS FOR CANCER SURVIVORS: The implementation of prehabilitation interventions for individuals diagnosed with breast cancer should be utilised by multidisciplinary teams to provide holistic care to patients as it has the potential to improve outcomes across the cancer care trajectory.
Authors: Frederico Soares Falcetta; Henrique de Araújo Vianna Träsel; Fernando Kude de Almeida; Mariana Rangel Ribeiro Falcetta; Maicon Falavigna; Daniela Dornelles Rosa Journal: Breast Cancer Res Treat Date: 2018-04-13 Impact factor: 4.872
Authors: Mary Ann Burg; Gail Adorno; Ellen D S Lopez; Victoria Loerzel; Kevin Stein; Cara Wallace; Dinghy Kristine B Sharma Journal: Cancer Date: 2015-01-12 Impact factor: 6.860
Authors: Nicholas Zdenkowski; Stephanie Tesson; Janine Lombard; Melanie Lovell; Sandra Hayes; Prudence A Francis; Haryana M Dhillon; Frances M Boyle Journal: Med J Aust Date: 2016-11-21 Impact factor: 7.738
Authors: Dean Vuksanovic; Jasotha Sanmugarajah; Dominic Lunn; Raja Sawhney; Kelly Eu; Rhea Liang Journal: Breast Cancer Date: 2020-09-14 Impact factor: 4.239
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Reshma Jagsi; Kevin C Ward; Paul H Abrahamse; Lauren P Wallner; Allison W Kurian; Ann S Hamilton; Steven J Katz; Sarah T Hawley Journal: Cancer Date: 2018-07-23 Impact factor: 6.921